EC Number | Cloned (Comment) | Organism |
---|---|---|
2.3.1.297 | gene CERS2, recombinant expression in HEK-293 cells | Homo sapiens |
2.3.1.299 | gene CERS1, recombinant expression in HEK-293 cells | Homo sapiens |
EC Number | Metals/Ions | Comment | Organism | Structure |
---|---|---|---|---|
2.3.1.297 | Mg2+ | activates | Homo sapiens | |
2.3.1.299 | Mg2+ | activates | Homo sapiens |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.3.1.297 | dihydrosphingosine + lignoceroyl-CoA | Homo sapiens | - |
N-lignoceroyldihydrosphingosine + CoA | - |
? | |
2.3.1.297 | dihydrosphingosine + nervonoyl-CoA | Homo sapiens | - |
N-nervonoyldihydrosphingosine + CoA | - |
? | |
2.3.1.299 | dihydrosphingosine + palmitoyl-CoA | Homo sapiens | low activity | N-palmitoyldihydrosphingosine + CoA | - |
? | |
2.3.1.299 | dihydrosphingosine + stearoyl-CoA | Homo sapiens | highly preferred substrate | N-stearoyldihydrosphingosine + CoA | - |
? | |
2.3.1.299 | additional information | Homo sapiens | clear preference for the C18:0 NBD-dihydroceramide synthesis is observed with extracts of human frontal cortex grey matter | ? | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.3.1.297 | Homo sapiens | Q96G23 | - |
- |
2.3.1.299 | Homo sapiens | P27545 | - |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
2.3.1.297 | brain | - |
Homo sapiens | - |
2.3.1.297 | U-87MG cell | - |
Homo sapiens | - |
2.3.1.299 | brain | - |
Homo sapiens | - |
2.3.1.299 | neuron | CERS1 is highly expressed in neurons | Homo sapiens | - |
2.3.1.299 | U-87MG cell | - |
Homo sapiens | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.3.1.297 | dihydrosphingosine + lignoceroyl-CoA | - |
Homo sapiens | N-lignoceroyldihydrosphingosine + CoA | - |
? | |
2.3.1.297 | dihydrosphingosine + lignoceroyl-CoA | low activity | Homo sapiens | N-lignoceroyldihydrosphingosine + CoA | - |
? | |
2.3.1.297 | dihydrosphingosine + nervonoyl-CoA | - |
Homo sapiens | N-nervonoyldihydrosphingosine + CoA | - |
? | |
2.3.1.297 | dihydrosphingosine + nervonoyl-CoA | highly preferred substrate | Homo sapiens | N-nervonoyldihydrosphingosine + CoA | - |
? | |
2.3.1.297 | dihydrosphingosine + palmitoyl-CoA | low activity | Homo sapiens | N-palmitoyldihydrosphingosine + CoA | - |
? | |
2.3.1.297 | dihydrosphingosine + stearoyl-CoA | low activity | Homo sapiens | N-stearoyldihydrosphingosine + CoA | - |
? | |
2.3.1.297 | additional information | CERS2 preferentially transfers very long chain fatty acids (C22:0-C26:0) to dihydrosphingosine. Improvement of a fluorescent assay, using HPLC using C16:0, C18:0 and C24:1 fatty acids and commercially available sphinganine-NBD, i.e. 7-nitro-2-1,3-benzoxadiazole-labelled dihydrosphingosine or (2S,3R)-2-amino-18((7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)amino)octadecane-1-3-diol, as substrates, very accurate and sensitive method for quantification of CERS activity, method evaluation | Homo sapiens | ? | - |
? | |
2.3.1.299 | dihydrosphingosine + palmitoyl-CoA | low activity | Homo sapiens | N-palmitoyldihydrosphingosine + CoA | - |
? | |
2.3.1.299 | dihydrosphingosine + stearoyl-CoA | highly preferred substrate | Homo sapiens | N-stearoyldihydrosphingosine + CoA | - |
? | |
2.3.1.299 | additional information | clear preference for the C18:0 NBD-dihydroceramide synthesis is observed with extracts of human frontal cortex grey matter | Homo sapiens | ? | - |
? | |
2.3.1.299 | additional information | CERS1-expressing HEK293 cell extracts show a clear preference for utilisation of the C18:0 fatty acid substrate when presented with equimolar concentrations of C16:0, C18:0, C24:0, and C24:1 fatty acid substrates. CERS1 preferentially catalyses the addition of 18-carbon (C18:0) fatty acids to dihydrosphingosine. No activity with lignoceroyl-CA, and poor activity with nervonoyl-CoA. Improvement of a fluorescent assay, using HPLC using C16:0, C18:0, and C24:1 fatty acids and commercially available sphinganine-NBD, i.e. 7-nitro-2-1,3-benzoxadiazole-labelled dihydrosphingosine or (2S,3R)-2-amino-18((7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)amino)octadecane-1-3-diol, as substrates, very accurate and sensitive method for quantification of CERS activity, method evaluation | Homo sapiens | ? | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.3.1.297 | ceramide synthase 2 | - |
Homo sapiens |
2.3.1.297 | CerS2 | - |
Homo sapiens |
2.3.1.299 | ceramide synthase 1 | - |
Homo sapiens |
2.3.1.299 | CerS1 | - |
Homo sapiens |
EC Number | Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|---|
2.3.1.297 | 37 | - |
assay at | Homo sapiens |
2.3.1.299 | 37 | - |
assay at | Homo sapiens |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
2.3.1.297 | 7.4 | - |
assay at | Homo sapiens |
2.3.1.299 | 7.4 | - |
assay at | Homo sapiens |
EC Number | General Information | Comment | Organism |
---|---|---|---|
2.3.1.297 | physiological function | very long chain ceramides synthesized by CERS2 are essential constituents of myelin. CERS2 demonstrates a preference for the monounsaturated C24:1 fatty acid substrate compared to the saturated C24:0 substrate, potentially explaining why myelin is enriched in ceramides containing the monounsaturated form of very long chain fatty acids | Homo sapiens |
2.3.1.299 | physiological function | C18 ceramide synthesized by CERS1 is implicated in apoptosis and lethal autophagy | Homo sapiens |